Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 1296056

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1296056

Global Dry Eye Syndrome Drugs Market 2023-2027

PUBLISHED:
PAGES: 161 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

The dry eye syndrome drugs market is forecasted to grow by USD 2,159.21 mn during 2022-2027, accelerating at a CAGR of 6.53% during the forecast period. The report on the dry eye syndrome drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a growing geriatric population, growing healthcare expenditure, and changing lifestyles and rising cases of diseases contributing to dry eye syndrome.

Technavio's dry eye syndrome drugs market is segmented as below:

By Distribution Channel

  • Retail pharmacies
  • Hospital pharmacies
  • Online pharmacies

By Product

  • OTC drugs
  • Prescription drugs

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the advancements in drug delivery technologies as one of the prime reasons driving the dry eye syndrome drugs market growth during the next few years. Also, advancements in diagnostic techniques for dry eye syndrome and the shift of dry eye syndrome drugs toward personalized medicine will lead to sizable demand in the market.

The report on the dry eye syndrome drugs market covers the following areas:

  • Dry eye syndrome drugs market sizing
  • Dry eye syndrome drugs market forecast
  • Dry eye syndrome drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dry eye syndrome drugs market vendors that include Abbott Laboratories, AbbVie Inc., AFT Pharmaceuticals Ltd., Akorn Operating Co. LLC, Bausch Health Co. Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, I MED Pharma Inc., Johnson and Johnson Services Inc., Laboratoires THEA SAS, Mitotech SA, Novaliq GmbH, Novartis AG, Oasis Medical Inc., Otsuka Holdings Co. Ltd., Santen Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Viatris Inc., and Visufarma. Also, the dry eye syndrome drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR46644

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global dry eye syndrome drugs market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global dry eye syndrome drugs market 2017 - 2021 ($ million)
  • 4.2 Distribution Channel Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
  • 4.3 Product Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel

  • 6.1 Market segments
  • Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
  • 6.2 Comparison by Distribution Channel
  • Exhibit 32: Chart on Comparison by Distribution Channel
  • Exhibit 33: Data Table on Comparison by Distribution Channel
  • 6.3 Retail pharmacies - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
  • 6.4 Hospital pharmacies - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
  • 6.5 Online pharmacies - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
  • 6.6 Market opportunity by Distribution Channel
  • Exhibit 46: Market opportunity by Distribution Channel ($ million)
  • Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Product

  • 7.1 Market segments
  • Exhibit 48: Chart on Product - Market share 2022-2027 (%)
  • Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
  • 7.2 Comparison by Product
  • Exhibit 50: Chart on Comparison by Product
  • Exhibit 51: Data Table on Comparison by Product
  • 7.3 OTC drugs - Market size and forecast 2022-2027
  • Exhibit 52: Chart on OTC drugs - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Data Table on OTC drugs - Market size and forecast 2022-2027 ($ million)
  • Exhibit 54: Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)
  • 7.4 Prescription drugs - Market size and forecast 2022-2027
  • Exhibit 56: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ million)
  • Exhibit 58: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
  • Exhibit 59: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by Product
  • Exhibit 60: Market opportunity by Product ($ million)
  • Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 65: Chart on Geographic comparison
  • Exhibit 66: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 UK - Market size and forecast 2022-2027
  • Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.9 Japan - Market size and forecast 2022-2027
  • Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.10 Germany - Market size and forecast 2022-2027
  • Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.11 China - Market size and forecast 2022-2027
  • Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 103: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 105: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 107: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 108: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 109: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 110: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories
  • Exhibit 111: Abbott Laboratories - Overview
  • Exhibit 112: Abbott Laboratories - Business segments
  • Exhibit 113: Abbott Laboratories - Key news
  • Exhibit 114: Abbott Laboratories - Key offerings
  • Exhibit 115: Abbott Laboratories - Segment focus
  • 12.4 AbbVie Inc.
  • Exhibit 116: AbbVie Inc. - Overview
  • Exhibit 117: AbbVie Inc. - Product / Service
  • Exhibit 118: AbbVie Inc. - Key news
  • Exhibit 119: AbbVie Inc. - Key offerings
  • 12.5 AFT Pharmaceuticals Ltd.
  • Exhibit 120: AFT Pharmaceuticals Ltd. - Overview
  • Exhibit 121: AFT Pharmaceuticals Ltd. - Business segments
  • Exhibit 122: AFT Pharmaceuticals Ltd. - Key offerings
  • Exhibit 123: AFT Pharmaceuticals Ltd. - Segment focus
  • 12.6 Bausch Health Co. Inc.
  • Exhibit 124: Bausch Health Co. Inc. - Overview
  • Exhibit 125: Bausch Health Co. Inc. - Business segments
  • Exhibit 126: Bausch Health Co. Inc. - Key news
  • Exhibit 127: Bausch Health Co. Inc. - Key offerings
  • Exhibit 128: Bausch Health Co. Inc. - Segment focus
  • 12.7 I MED Pharma Inc.
  • Exhibit 129: I MED Pharma Inc. - Overview
  • Exhibit 130: I MED Pharma Inc. - Product / Service
  • Exhibit 131: I MED Pharma Inc. - Key offerings
  • 12.8 Johnson and Johnson Services Inc.
  • Exhibit 132: Johnson and Johnson Services Inc. - Overview
  • Exhibit 133: Johnson and Johnson Services Inc. - Business segments
  • Exhibit 134: Johnson and Johnson Services Inc. - Key news
  • Exhibit 135: Johnson and Johnson Services Inc. - Key offerings
  • Exhibit 136: Johnson and Johnson Services Inc. - Segment focus
  • 12.9 Laboratoires THEA SAS
  • Exhibit 137: Laboratoires THEA SAS - Overview
  • Exhibit 138: Laboratoires THEA SAS - Product / Service
  • Exhibit 139: Laboratoires THEA SAS - Key offerings
  • 12.10 Mitotech SA
  • Exhibit 140: Mitotech SA - Overview
  • Exhibit 141: Mitotech SA - Product / Service
  • Exhibit 142: Mitotech SA - Key offerings
  • 12.11 Novaliq GmbH
  • Exhibit 143: Novaliq GmbH - Overview
  • Exhibit 144: Novaliq GmbH - Product / Service
  • Exhibit 145: Novaliq GmbH - Key offerings
  • 12.12 Novartis AG
  • Exhibit 146: Novartis AG - Overview
  • Exhibit 147: Novartis AG - Business segments
  • Exhibit 148: Novartis AG - Key offerings
  • Exhibit 149: Novartis AG - Segment focus
  • 12.13 Oasis Medical Inc.
  • Exhibit 150: Oasis Medical Inc. - Overview
  • Exhibit 151: Oasis Medical Inc. - Product / Service
  • Exhibit 152: Oasis Medical Inc. - Key offerings
  • 12.14 Otsuka Holdings Co. Ltd.
  • Exhibit 153: Otsuka Holdings Co. Ltd. - Overview
  • Exhibit 154: Otsuka Holdings Co. Ltd. - Business segments
  • Exhibit 155: Otsuka Holdings Co. Ltd. - Key offerings
  • Exhibit 156: Otsuka Holdings Co. Ltd. - Segment focus
  • 12.15 Santen Pharmaceutical Co. Ltd.
  • Exhibit 157: Santen Pharmaceutical Co. Ltd. - Overview
  • Exhibit 158: Santen Pharmaceutical Co. Ltd. - Product / Service
  • Exhibit 159: Santen Pharmaceutical Co. Ltd. - Key offerings
  • 12.16 Sun Pharmaceutical Industries Ltd.
  • Exhibit 160: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibit 161: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibit 162: Sun Pharmaceutical Industries Ltd. - Key offerings
  • 12.17 Viatris Inc.
  • Exhibit 163: Viatris Inc. - Overview
  • Exhibit 164: Viatris Inc. - Business segments
  • Exhibit 165: Viatris Inc. - Key news
  • Exhibit 166: Viatris Inc. - Key offerings
  • Exhibit 167: Viatris Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 168: Inclusions checklist
  • Exhibit 169: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 170: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 171: Research methodology
  • Exhibit 172: Validation techniques employed for market sizing
  • Exhibit 173: Information sources
  • 13.5 List of abbreviations
  • Exhibit 174: List of abbreviations
Product Code: IRTNTR46644

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on global dry eye syndrome drugs market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Distribution Channel
  • Exhibits33: Data Table on Comparison by Distribution Channel
  • Exhibits34: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
  • Exhibits44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
  • Exhibits46: Market opportunity by Distribution Channel ($ million)
  • Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
  • Exhibits48: Chart on Product - Market share 2022-2027 (%)
  • Exhibits49: Data Table on Product - Market share 2022-2027 (%)
  • Exhibits50: Chart on Comparison by Product
  • Exhibits51: Data Table on Comparison by Product
  • Exhibits52: Chart on OTC drugs - Market size and forecast 2022-2027 ($ million)
  • Exhibits53: Data Table on OTC drugs - Market size and forecast 2022-2027 ($ million)
  • Exhibits54: Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)
  • Exhibits56: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ million)
  • Exhibits57: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ million)
  • Exhibits58: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
  • Exhibits60: Market opportunity by Product ($ million)
  • Exhibits61: Data Table on Market opportunity by Product ($ million)
  • Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits65: Chart on Geographic comparison
  • Exhibits66: Data Table on Geographic comparison
  • Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits93: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits103: Market opportunity By Geographical Landscape ($ million)
  • Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits105: Impact of drivers and challenges in 2022 and 2027
  • Exhibits106: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits107: Overview on factors of disruption
  • Exhibits108: Impact of key risks on business
  • Exhibits109: Vendors covered
  • Exhibits110: Matrix on vendor position and classification
  • Exhibits111: Abbott Laboratories - Overview
  • Exhibits112: Abbott Laboratories - Business segments
  • Exhibits113: Abbott Laboratories - Key news
  • Exhibits114: Abbott Laboratories - Key offerings
  • Exhibits115: Abbott Laboratories - Segment focus
  • Exhibits116: AbbVie Inc. - Overview
  • Exhibits117: AbbVie Inc. - Product / Service
  • Exhibits118: AbbVie Inc. - Key news
  • Exhibits119: AbbVie Inc. - Key offerings
  • Exhibits120: AFT Pharmaceuticals Ltd. - Overview
  • Exhibits121: AFT Pharmaceuticals Ltd. - Business segments
  • Exhibits122: AFT Pharmaceuticals Ltd. - Key offerings
  • Exhibits123: AFT Pharmaceuticals Ltd. - Segment focus
  • Exhibits124: Bausch Health Co. Inc. - Overview
  • Exhibits125: Bausch Health Co. Inc. - Business segments
  • Exhibits126: Bausch Health Co. Inc. - Key news
  • Exhibits127: Bausch Health Co. Inc. - Key offerings
  • Exhibits128: Bausch Health Co. Inc. - Segment focus
  • Exhibits129: I MED Pharma Inc. - Overview
  • Exhibits130: I MED Pharma Inc. - Product / Service
  • Exhibits131: I MED Pharma Inc. - Key offerings
  • Exhibits132: Johnson and Johnson Services Inc. - Overview
  • Exhibits133: Johnson and Johnson Services Inc. - Business segments
  • Exhibits134: Johnson and Johnson Services Inc. - Key news
  • Exhibits135: Johnson and Johnson Services Inc. - Key offerings
  • Exhibits136: Johnson and Johnson Services Inc. - Segment focus
  • Exhibits137: Laboratoires THEA SAS - Overview
  • Exhibits138: Laboratoires THEA SAS - Product / Service
  • Exhibits139: Laboratoires THEA SAS - Key offerings
  • Exhibits140: Mitotech SA - Overview
  • Exhibits141: Mitotech SA - Product / Service
  • Exhibits142: Mitotech SA - Key offerings
  • Exhibits143: Novaliq GmbH - Overview
  • Exhibits144: Novaliq GmbH - Product / Service
  • Exhibits145: Novaliq GmbH - Key offerings
  • Exhibits146: Novartis AG - Overview
  • Exhibits147: Novartis AG - Business segments
  • Exhibits148: Novartis AG - Key offerings
  • Exhibits149: Novartis AG - Segment focus
  • Exhibits150: Oasis Medical Inc. - Overview
  • Exhibits151: Oasis Medical Inc. - Product / Service
  • Exhibits152: Oasis Medical Inc. - Key offerings
  • Exhibits153: Otsuka Holdings Co. Ltd. - Overview
  • Exhibits154: Otsuka Holdings Co. Ltd. - Business segments
  • Exhibits155: Otsuka Holdings Co. Ltd. - Key offerings
  • Exhibits156: Otsuka Holdings Co. Ltd. - Segment focus
  • Exhibits157: Santen Pharmaceutical Co. Ltd. - Overview
  • Exhibits158: Santen Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits159: Santen Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits160: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibits161: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibits162: Sun Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits163: Viatris Inc. - Overview
  • Exhibits164: Viatris Inc. - Business segments
  • Exhibits165: Viatris Inc. - Key news
  • Exhibits166: Viatris Inc. - Key offerings
  • Exhibits167: Viatris Inc. - Segment focus
  • Exhibits168: Inclusions checklist
  • Exhibits169: Exclusions checklist
  • Exhibits170: Currency conversion rates for US$
  • Exhibits171: Research methodology
  • Exhibits172: Validation techniques employed for market sizing
  • Exhibits173: Information sources
  • Exhibits174: List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!